Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 March 2023 | Story André Damons | Photo Reuben Maeko
Dr William Mhundwa
Prof Thabiso Mofokeng, Head of Department: Internal Medicine, and Dr Busiswa Bisiwe, Head of the Unit: Nephrology and Dr William Mhundwa’s (right) supervisor, congratulates him on his great achievement.

Dr William Mhundwa, Senior Registrar in the Department of Internal Medicine at the University of the Free State (UFS), has become the first candidate from the institution to be awarded the prestigious Suzman Medal as the top student in the 2022 examinations of the Fellowship of the College of Physicians (FCP).  

Candidates from all medical schools in the country as well as other African countries wrote this examination in January and July 2022. Dr Mhundwa came out on top and was awarded the medal by the Senate of the Colleges of Medicine of South Africa (CMSA), which oversees the examinations.  

“I congratulate Dr Mhundwa on his outstanding performance,” commented Prof Nicholas Pearce, Head of the School: Clinical Medicine at the UFS. According to him, this is a prestigious award, and given that it is the first time that a candidate from this university has been awarded this medal, it is extra special for us as a department, faculty, and institution. 

Dr Mhundwa was born in Harare, Zimbabwe, to subsistence farmers and is the eldest of four boys. He immigrated to South Africa nearly ten years ago and started studying medicine as a way to fulfil his parents’ dreams. He eventually found his calling in internal medicine, specifically nephrology (kidney disease), and would like to obtain further qualifications in this field at the university. 

 “My achievements are the result of dedication to teaching internal medicine consultants. I am indebted to the Free State Department of Health for the opportunity to train and work under them. I hope to see great academic achievements within this province,” says Dr Mhundwa. 

He will graduate in April 2023 with a Master of Medicine, cum laude. His thesis was about The Prevalence of Chronic Kidney Disease Among Type 2 Diabetes Mellitus Patients in Central South Africa

Dr Mhundwa believes “that kidney disease is a scourge in modern society.  Early diagnosis is necessary to prevent patients from requiring kidney transplants and dialysis and to improve the quality of life of my patients”.

Prof Thabiso Mofokeng, Head of Department: Internal Medicine, said, “This achievement represents the UFS’ high academic standards on national front. We hope this is the first of many.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept